Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.7.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2017
Dec. 31, 2016
Current assets    
Cash and cash equivalents $ 1,690,701 $ 7,751,557
Accounts receivable 4,208,414 3,553,096
Inventory 909,057 609,072
Prepaid expenses and other assets 196,158 199,495
Total current assets 7,004,330 12,113,220
Property and Equipment, net 2,890,270 2,569,354
Deferred tax asset 500,000 500,000
Patents, net 3,034,472
Patent rights, net 52,945
Customer acquisition costs, net 421,389 642,203
Total assets 13,850,461 15,877,722
Current liabilities    
Accounts payable and accrued expenses 2,174,868 4,363,553
Current portion of notes payable 2,250,000 1,500,000
Current portion of equipment notes payable 59,132 39,499
Customer credits 551,750 590,206
Total current liabilities 5,035,750 6,493,258
Notes payable, net of discount and issuance costs 10,739,222 11,678,669
Convertible notes payable, net of discount and issuance costs 1,253,300 1,142,154
Warrant liability 219,000 1,313,000
Accrued interest 77,500 78,750
Equipment notes payable 198,268 143,135
Total liabilities 17,523,040 20,848,966
Stockholders' deficit    
Preferred stock, $.001 par value: 2,000,000 shares authorized
Common stock; $.001 par value; 150,000,000 shares authorized; 75,246,113 shares issued and outstanding as of June 30, 2017 73,509,663 shares issued and outstanding as of December 31, 2016 75,246 73,510
Additional paid-in capital 51,909,207 49,838,469
Accumulated deficit (55,657,032) (54,883,223)
Total stockholders' deficit (3,672,579) (4,971,244)
Total liabilities and stockholders' deficit $ 13,850,461 $ 15,877,722